Based on 20 years of research conducted by the founder Prof. Nesrin Özören, Vaccizone developed and patented a novel method for an antigen/bioactive delivery which increases both the antigenicity of the antigen as well as enhancing its stability at high temperatures, freeze thaw cycles and organic solvents. Utilizing its unique platform, Vaccizone is helping pharma industry leaders and governments to save lives.